Deutsche Bank maintains a Buy rating on Sanofi (SNY)
Sanofi (NASDAQ:SNY) is one of the The best low-volatility, large-cap stocks to invest in.. Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Sanofi (NASDAQ:SNY) on November 25, setting a price target of €110. Is Sanofi (SNY) the best gene editing stock to buy? On the same day, Sanofi (NASDAQ:SNY) announced the approval of…